| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2025 , Vol 63 , Num 1
The role of hypoxia-inducible factor 1 alpha and peroxisome proliferator activated receptor gamma coactivator 1 alpha in the diagnosis of breast cancer
1 Al-Nahrain University, College of Medicine, Department of Chemistry and Biochemistry, Baghdad, Iraq, 2 Al-Nahrain University, College of Medicine, Department of Surgery, Baghdad, Iraq, 3 Ministry of Health and Environment, Oncology Teaching Hospital, Baghdad, Iraq
DOI :
10.23893/1307-2080.APS6304